T. Rowe Price Associates’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.05M | Sell |
|
|||||
|
2020
Q4 | $28.9M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $85K | Buy |
|
|||||
|
2019
Q4 | $91K | Buy |
|
|||||
|
2019
Q3 | $70K | Buy |
|
|||||
|
2019
Q2 | $109K | Sell |
|
|||||
|
2019
Q1 | $13.7M | Sell |
|
|||||
|
2018
Q4 | $9.61M | Sell |
|
|||||
|
2018
Q3 | $14.5M | Buy |
|
|||||
|
2018
Q2 | $16.4M | Sell |
|
|||||
|
2018
Q1 | $19.5M | Buy |
|
|||||
|
2017
Q4 | $6.16M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.61M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $13.2M | Sell |
|
|||||
|
2015
Q3 | $9.38M | Sell |
|
|||||
|
2015
Q2 | $15.4M | Sell |
|
|||||
|
2015
Q1 | $14.2M | Buy |
|
|||||
|
2014
Q4 | $11.3M | Buy |
|
|||||
|
2014
Q3 | $2.94M | Buy |
|